DO JUNIOR DOCTORS PRESCRIBE DISEASE MODIFYING ANTI RHEUMATIC DRUGS SAFELY?

被引：0
|
作者：
Nisar, M. K. [1 ]
Weller, H. [1 ]
机构：
[1] Luton & Dunstable Univ Hosp, Rheumatol, Luton, Beds, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.1691
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0592
引用
收藏
页码：430 / 430
页数：1
相关论文
共 50 条
  • [31] TUBERCULOSIS RISK IN CHILDREN WITH RHEUMATIC DISEASES TREATED WITH BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Kavadichanda, C.
    Ajmani, S.
    Maccora, I.
    Balan, S.
    Ramanan, A.
    Agarwal, V.
    Gupta, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1784 - 1785
  • [32] Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
    Soroush Moradi
    Maryam Masoumi
    Somayeh Mohammadi
    Jamshid Vafaeimanesh
    Mohaddeseh Mohseni
    Hossein Mahdavi
    Armin Aryannejad
    Internal and Emergency Medicine, 2021, 16 : 919 - 923
  • [33] CONTRACEPTIVE USE IN WOMEN WITH RHEUMATOLOGIC DISEASE TAKING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    O'Neill, C.
    Ngian, G.
    Nicholson, P.
    Van Doornum, S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 44 - 44
  • [34] Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B
    King, L. K.
    Lee, A.
    Anandacoomarasamy, A.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (05) : 523 - 531
  • [35] Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs
    Moradi, Soroush
    Masoumi, Maryam
    Mohammadi, Somayeh
    Vafaeimanesh, Jamshid
    Mohseni, Mohaddeseh
    Mahdavi, Hossein
    Aryannejad, Armin
    INTERNAL AND EMERGENCY MEDICINE, 2021, 16 (04) : 919 - 923
  • [36] ADHERENCE AND PERSISTENCE TO DISEASE MODIFYING ANTI RHEUMATIC DRUGS IN COLOMBIAN PATIENTS WITH RHEUMATOID ARTHRITIS
    Pertuz-Charris, N.
    Ochoa-Jaramillo, F. L.
    Gil-Calderon, D.
    Alzate-Vinasco, M. A.
    Velez-Marin, V.
    Hernandez-Parra, D.
    Pineda-Tamayo, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 326 - 326
  • [37] Parasitic helminths and protozoa: Treasure boxes of disease modifying anti-rheumatic drugs
    Osada, Yoshio
    Shimizu, Shoichi
    Morita, Kentaro
    PARASITOLOGY INTERNATIONAL, 2025, 105
  • [38] Cardiovascular Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
    Drakopoulou, Maria
    Soulaidopoulos, Stergios
    Oikonomou, George
    Tousoulis, Dimitrios
    Toutouzas, Konstantinos
    CURRENT VASCULAR PHARMACOLOGY, 2020, 18 (05) : 488 - 506
  • [39] PATIENTS' BELIEFS RELATING TO THE USE AND EFFICACY OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Goodacre, L. J.
    Smith, J.
    Goodacre, J. A.
    RHEUMATOLOGY, 2002, 41 : 73 - 73
  • [40] Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
    Atzeni, Fabiola
    Gerratana, Elisabetta
    Francesco Masala, Ignazio
    Bongiovanni, Sara
    Sarzi-Puttini, Piercarlo
    Rodriguez-Carrio, Javier
    FRONTIERS IN MEDICINE, 2021, 8
12345